Dr.Cremona Tiziana Patrizia holds a strong academic and research background in cellular and molecular biology. She studied cellular and molecular biology at University of Rome Tor Vergata, she continued her education and received a master on Biology applied at Biomedical Research at University of Rome La Sapienza. Her academicjourney continued obtaining a PhD in Biomedical Science at the University of Bern focusing on development of emphysema caused by cigarette smoke exposure.
In 2017, Dr Cremona was awarded a fellowship at Harvard University to further her studies on lung remodeling and asthma models.
She is currently a senior Post-doc at the University of Bern, Department for Biomedical Research working in the Lung Precision Medicine program focusing on a rare lung disease: Alpha 1 antitrypsin deficiency.
Her current project “Cell specific gene editing as treatment of Alpha 1 antitrypsin deficiency” aims to aims to develop a novel model for targeted gene editing to prevent disease progression. This research goes beyond correlation studies, seeking to definitively address critical questions surrounding disease mechanisms and therapeutic interventions.